摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Fubimina | 1984789-90-3

中文名称
——
中文别名
——
英文名称
Fubimina
英文别名
[1-(5-fluoropentyl)benzimidazol-2-yl]-naphthalen-1-ylmethanone
Fubimina化学式
CAS
1984789-90-3
化学式
C23H21FN2O
mdl
——
分子量
360.4
InChiKey
KUESSZMROAFKQJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    34.9
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS
    申请人:Pascal Biosciences Inc.
    公开号:EP3743061A1
    公开(公告)日:2020-12-02
  • [EN] CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS<br/>[FR] CANNABINOÏDES ET LEURS DÉRIVÉS POUR FAVORISER L'IMMUNOGÉNICITÉ DES CELLULES TUMORALES ET INFECTÉES
    申请人:PASCAL BIOSCIENCES INC
    公开号:WO2019144126A1
    公开(公告)日:2019-07-25
    This invention provides processes and compositions for enhancing the immunogenicity of tumor or infected cells by increasing expression of major histocompatibility complex (MHC) class I surface molecules. Tumor cells often circumvent immune recognition by reducing or eliminating MHC expression. The lack of MHC on their surface allows tumor cells to evade immune detection and enables uncontrolled growth. Similarly, certain viral or microbial infections result in MHC class I downregulation and the resulting immune evasion. With a unique reporter assay, we have determined that some cannabinoid compounds and structural analogs can increase MHC class I expression on tumor cells grown in cell culture. The increase of tumor and infected cell MHC class I expression will enable detection and destruction by cytotoxic T-lymphocyte cells. The process and compositions increase the immunogenicity of the target cells, e.g. tumor or infected cells, to enhance their destruction by cytotoxic lymphocytes. When administered in combination, such compositions may enhance the activity of immune- oncology and anti-infectious disease agents.
查看更多